| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |